Cholesterol transport between red blood cells and lipoproteins contributes to cholesterol metabolism in blood
Ryunosuke Ohkawa(The University of Tokyo), Minoru Tozuka(Tokyo Medical and Dental University), Peter J. Meikle(Baker Heart and Diabetes Institute), Shao-Jui Lai(Tokyo Medical and Dental University), Mai Sasaoka(Tokyo Medical and Dental University), Hann Low(Baker Heart and Diabetes Institute), Boris Vaisman(National Institutes of Health), Yuna Horiuchi(Tokyo Medical and Dental University), Paul J. Nestel(Baker Heart and Diabetes Institute), Takahiro Kameda(Tokyo Medical and Dental University), Gerard Pernes(Dana-Farber Cancer Institute), Graeme I. Lancaster(RMIT University), Nigora Mukhamedova(Baker Heart and Diabetes Institute), Dmitri Sviridov(Baker Heart and Diabetes Institute), Denis Sviridov(National Institutes of Health), Azusa Yamazaki(Tokyo Medical and Dental University), Ayuko Hara(Tokyo Medical and Dental University), Denis Sviridov(National Institutes of Health), Alan T. Remaley(National Institutes of Health), Michael Ditiatkovski(Baker Heart and Diabetes Institute), Andrew Murphy(National Institutes of Health), Ying Fu(Baker Heart and Diabetes Institute)
Cited by 40
Related Papers
Exosome-dependent Trafficking of HSP70
|Journal of Biological Chemistry|2005|533
Human Immunodeficiency Virus Impairs Reverse Cholesterol Transport from Macrophages
|PLoS Biology|2006|336
MS-based lipidomics of human blood plasma: a community-initiated position paper to develop accepted guidelines
|Journal of Lipid Research|2018|325
Mitochondrial dysfunction-related lipid changes occur in nonalcoholic fatty liver disease progression
|Journal of Lipid Research|2018|226